Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

RVTY · Revvity, Inc.

$120.94 -2.35% Sep 10 close
Detected setup Wyckoff SOS · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about RVTY

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$RVTY

Revvity, Inc.

Revvity, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $13B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 1
$120.94 latest close
Verdict · setup score 55/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

Next earnings Monday, October 26, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

RVTY-2.35%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. -1.75 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-2.35% From the open-1.22% Range position2% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $120.94 -2.4% Sep 10 close
52W High $133.00 9.1% below high
Wks Since High 0w
Base Depth 9.1%
RS Rank 70 percentile of scan
SMA 50 $117.12
Avg Vol 1,488,275
Rel Vol (Sep 10) 0.90×
More stats
52W Low $81.22
Tight Wks 0
Base B1
SMA 200 $102.83
RS Line vs High -6.7%
RS Line Slope +5.7% ▲
Group Rank #25/58
ADR% 2.9%
ATR(14) $3.69 (3.0%)
Vol Pace (live) N/A
U/D Vol 1.20
A/D Days 19A / 10D
A/D Rating A+
VDU Bars 0/10 d
Earnings in 44d
Position in 52-week range 77thpercentile of the 52-week range
$81.22low
$133.00high

RVTY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for RVTY.

Create Free Account

Technical Analysis Report Card

$RVTY · $120.94 · as of 2026-09-10 · multi-factor read
75
/ 100
Technicals 75/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$117.12 ↑
100-day$107.41 ↑
200-day$102.83 ↑
Bullish (50 > 200)

RSI (14)

Reading47.3 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.862

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width34% · 16.9%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.2 · Neutral
Rel volume0.9×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.

Support & Resistance

R · $133.0052-week high
Price · $120.94now
S · $113.69swing level
S · $107.88swing level
S · $102.36swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$120.78
38.2%$113.22
50.0%$107.11
61.8%$101.00
78.6%$92.30

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for RVTY — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about RVTY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini C

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $120.94, MA150 $102.45, MA200 $102.83
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $117.12, MA150 $102.45, MA200 $102.83
Failing evidence
1.2 150-day MA > 200-day MAMA150 $102.45 vs MA200 $102.83
2. Quarterly EPS growth ≥ 25%From SEPA scan
7/12 checks
Avoid
O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B
N: Near 52-week high or RS line new high9.1% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 76
A: Annual earnings & revenue qualityRev +3.7%
3/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $120.94 vs MA200 $102.83
Failing evidence
Volume expansion above averageVolume ratio 0.90x
6/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$120.94
Relative strengthRS 76
Failing evidence
Volume vs average0.90x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$120.94
Relative strengthRS 76
Failing evidence
Volume vs average0.90x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$120.94
Relative strengthRS 76
Failing evidence
Volume vs average0.90x
Sign of Strength confirmed on expanding volume0.90x average volume — needs ≥1.4x
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
126RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +4 A+
A: 17 D: 13 Net: +465 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +4%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 76
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -9.1%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Wyckoff SOS Historical replay: +20% before −8% within 40 sessions: 27% (n=71) · source bars 2025-03-17–2026-09-04 · avg +4.1% per setup (+0.52R) ⚠ Extended past buy zone ⚠ Not actionable yet
55 setup score
RS Score 76
Trend template 7/8
CANSLIM 70.7* (B)
range low: 85.715 range high: 108.836 range pct: 0.27 sos thrust: 0.163 sos vol ratio: 2.274 sos bars ago: 6 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS · schematic

SOS: breakout above range_high=108.84, thrust=16.3%, vol=2.3x avg, lps=extended, 6 bars ago | Strong trend (7/8) | Good RS (76) | High-confidence pattern (80%) | Stage 2 | Readiness 62/100 (early) | CANSLIM 70.7 (B) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • A relative-strength leader — partly met RS rank 70 — middling
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.9× average — light
  • Clear of earnings — met in 44 days
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $120.94 vs SMA150 $102.45 / SMA200 $102.83
SMA 150 above SMA 200 SMA150 $102.45 vs SMA200 $102.83
SMA 200 trending up Slope +3.09 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $117.12
Price above SMA 50 $120.94 vs SMA50 $117.12
30%+ above 52-week low +48.9% from $81.22
Within 25% of 52-week high -9.1% from $133.00
RS score above 70 RS 76

Fundamentals

52W Range
77%
Mkt Cap SEC
13.5B
Rev YoY
+4%
EPS TTM
$2.07
P/E TTM
58.4x
Float
112M

Company

Company profile
Revvity, Inc.
RVTY · NYSE · Health Technology · Medical Specialties
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 70.7* CANSLIM * disqualified on M
C · Curr. EPS
70
A · Annual EPS
59
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
76
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
99
W. Support
$81.22
W. Resist
$133.00
Weekly Structure

Scan History

20× streak
Sep 09: 70 (Ascending Triangle)Sep 10: 59 (Wyckoff SOS)Sep 11: 55 (Wyckoff SOS)55
Sep 11
Wyckoff SOS ✓ Gate
55
Sep 10
Wyckoff SOS ✓ Gate
59 0.0%
Sep 09
Ascending Triangle ✓ Gate
70 -2.3%

Get the full picture on RVTY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial